ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
TransCode Therapeutics Inc

TransCode Therapeutics Inc (RNAZ)

0,3362
0,0082
(2,50%)
Fermé 21 Novembre 10:00PM
0,3362
0,00
( 0,00% )
Avant marché: 10:01AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
0,3362
Prix Achat
0,305
Prix Vente
0,37
Volume échangé
1
0,00 Fourchette du Jour 0,00
0,216 Plage de 52 semaines 18,664
Cap du marché
Clôture Veille
0,3362
Ouverture
-
Dernière Transaction
1
@
0.3698
Dernière heure de transaction
10:34:34
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 724 881
Actions en circulation
17 265 658
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,32
Bénéfice par action (BPA)
-1,07
Chiffre d'affairess
-
Bénéfice net
-18,55M

À propos de TransCode Therapeutics Inc

TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regre... TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
TransCode Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker RNAZ. Le dernier cours de clôture d'TransCode Therapeutics était de US$0,34. Au cours de la dernière année, les actions de TransCode Therapeutics ont été négociées dans une fourchette de prix de US$ 0,216 à US$ 18,664.

TransCode Therapeutics compte actuellement 17 265 658 actions en circulation. La capitalisation boursière d'TransCode Therapeutics est de US$5,80 million. TransCode Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.32.

RNAZ Dernières nouvelles

TransCode Therapeutics Open Letter to Shareholders

BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The Board and Management of TransCode Therapeutics (NASDAQ: RNAZ) today issued the following open letter to shareholders of the Company: Dear...

TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance

BOSTON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today...

TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data

The clinical trial Safety Review Committee (SRC) approved opening of Cohort 2 after review of safety data from the three patients comprising Cohort 1No significant safety or dose limiting...

TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology

Patients currently remain on study for continued treatment with TTX-MC138  No significant safety or dose limiting toxicities reportedTTX-MC138, an antisense oligonucleotide conjugated to...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0311-8.467193030220.36730.38230.31442002990.33781093CS
4-0.3198-48.750.6560.69690.3134489220.4746579CS
120.058320.97876934150.27790.80.222617248810.48120183CS
26-0.8638-71.98333333331.21.990.21613233870.52688167CS
52-8.8638-96.34565217399.218.6640.21614827712.60123879CS
156-2175.6638-99.9845496324217625040.2161493047211.63349313CS
260-4799.6638-99.9929958333480056000.2161679169852.74521267CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
WORXSCWorx Corporation
US$ 1,70
(73,47%)
5,38M
PETWag Group Company
US$ 0,322
(53,26%)
7,33M
CRKNCrown Electrokinetics Corporation
US$ 1,05
(33,64%)
1,94M
TCTMTCTM Kids IT Education Inc
US$ 1,09
(28,24%)
1
XTKGX3 Holdings Company Ltd
US$ 0,1135
(26,11%)
4,52M
WSBFWaterstone Financial Inc
US$ 9,00
(-40,98%)
4
PYXSPyxis Oncology Inc
US$ 2,35
(-38,48%)
78,26k
HSTMHealthStream Inc
US$ 20,00
(-36,10%)
102
PGCPeapack Gladstone Financial Corporation
US$ 26,00
(-29,27%)
99
CACCamden National Corporation
US$ 33,10
(-28,53%)
101
PETWag Group Company
US$ 0,322
(53,26%)
7,33M
WORXSCWorx Corporation
US$ 1,70
(73,47%)
5,38M
XTKGX3 Holdings Company Ltd
US$ 0,1135
(26,11%)
4,52M
CRKNCrown Electrokinetics Corporation
US$ 1,05
(33,64%)
1,94M
NVDANVIDIA Corporation
US$ 140,77
(-3,51%)
1,74M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées